365462-23-3
Chemical Structure
Darexaban
Synonym(s): YM150
- CAS No.: 365462-23-3
- Formula:C27H30N4O4
- Molecular Weight:474.55
IUPAC Name: N-(3-hydroxy-2-(4-(4-methyl-1,4-diazepan-1-yl)benzamido)phenyl)-4-methoxybenzamide
InChIKey: IJNIQYINMSGIPS-UHFFFAOYSA-N
SMILES: O=C(NC1=C(NC(C2=CC=C(OC)C=C2)=O)C=CC=C1O)C3=CC=C(N4CCN(C)CCC4)C=C3
Biological Activity: Darexaban (YM150) is a potent, selective and orally active factor Xa (FXa) inhibitor with an IC50 of 54.6 nM. Darexaban shows high selectivity against other related serine proteases, such as trypsin, thrombin, and kallikrein. Darexaban has anticoagulant and antithrombotic effects[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Darexaban | 98.05% | Darexaban (YM150) is a potent, selective and orally active factor Xa (FXa) inhibitor with an IC50 of 54.6 nM. Darexaban shows high selectivity against other related serine proteases, such as trypsin, thrombin, and kallikrein. Darexaban has anticoagulant and antithrombotic effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.89
HY-135541Darexaban maleate -
Similarity Score 0.67
HY-19866Darexaban glucuronide -
Similarity Score 0.62
HY-118803AS1468240 -
Similarity Score 0.60
HY-151884FUBP1-IN-2 -
Similarity Score 0.56
HY-19612ADDP-38003 dihydrochloride -
Similarity Score 0.56
HY-19347WDR5-0103 -
Similarity Score 0.55
HY-157412CRM1-IN-3 -
Similarity Score 0.55
HY-19612DDP-38003 -
Similarity Score 0.55
HY-Z9706Itraconazole impurity 18 -
Explore the MedChemAI to find more analogs
References
- [1]. Fukushi Hirayama, et al. Discovery of N-[2-hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (darexaban, YM150) as a potent and orally available factor Xa inhibitor. J Med Chem. 2011 Dec 8;54(23):8051-65. [Content Brief]
- [2]. Seiji Kaku, et al. Darexaban: anticoagulant effects in mice and human plasma in vitro, antithrombotic effects in thrombosis and bleeding models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa. Thromb Res. 2013 May;131(5):450-6. [Content Brief]
- [3]. Milan Remko, et al. Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors. Molecules. 2016 Feb 4;21(2):185. [Content Brief]
